Please use this identifier to cite or link to this item:
|Title:||Pneumocystis pneumonia with respiratory failure in a HIV-negative patient following short course of low-dose to moderate-dose prednisolone for a dermatological condition.||Austin Authors:||Borojevic, Branko;Johns, Esther;Raju, Nihal;Sycamnias, Lachlan Angus||Affiliation:||General Medicine..||Issue Date:||8-Jun-2022||Date:||2022||Publication information:||BMJ case reports 2022; 15(6): e249346.||Abstract:||A woman in her 80s was admitted with 5 days of progressive dyspnoea and hypoxic respiratory failure, in the setting of receiving a 3-week course of low-dose to moderate-dose prednisolone for a pruritic skin rash. Her medical history was not significant for major medical comorbidities or any other clear risk factors for secondary immunosuppression apart from advanced age. CT revealed widespread small-airway and parenchymal disease with ground-glass opacities consistent with atypical respiratory infection. Sputum PCR confirmed Pneumocystis jirovecii She was diagnosed with Pneumocystis jirovecii pneumonia (PJP) in the context of her clinical presentation, radiological features and PCR result. Her HIV status was negative. The patient was treated with 4 weeks of trimethoprim-sulfamethoxazole and 3 weeks of adjunctive prednisolone. She initially required high-dependency unit support with non-invasive ventilation. In this case report, we review the literature regarding PJP in the dermatology setting.||URI:||https://ahro.austin.org.au/austinjspui/handle/1/30314||DOI:||10.1136/bcr-2022-249346||Journal:||BMJ case reports||PubMed URL:||35675962||PubMed URL:||https://pubmed.ncbi.nlm.nih.gov/35675962/||Type:||Journal Article||Subjects:||Dermatology
Pneumonia (infectious disease)
|Appears in Collections:||Journal articles|
Show full item record
checked on Dec 1, 2023
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.